Xi He Xiao-Dong Jiao Ke Liu Bao-Dong Qin Ying Wu Yan Ling Jun Liu A-Qiao Xu Kun Song Yuan-Sheng Zang
10.1200/PO.20.00534
JCO Precis Oncol
2021 May 3;5:PO.20.00534.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/34036227/
Aminopyridines / therapeutic use Carbazoles / therapeutic use Colorectal Neoplasms / drug therapy Crizotinib / therapeutic use Lactams / therapeutic use Piperidines / therapeutic use Pyrazoles / therapeutic use
Aminopyridines / therapeutic use Carbazoles / therapeutic use Colorectal Neoplasms / drug therapy Crizotinib / therapeutic use Lactams / therapeutic use Piperidines / therapeutic use Pyrazoles / therapeutic use Case Reports Aged Anaplastic Lymphoma Kinase / genetics Antineoplastic Agents Colorectal Neoplasms / genetics Colorectal Neoplasms / pathology Female Gene Rearrangement Humans Neoplasm Metastasis Treatment Outcome Aminopyridines Antineoplastic Agents Carbazoles Lactams Piperidines Pyrazoles Crizotinib ALK protein, human Anaplastic Lymphoma Kinase alectinib lorlatinib
PMC8140796
34036227
Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report
2021